Pricing advanced medicines beyond the reach of the poor and encouraging neglect of diseases concentrated among them, the TRIPS Agreement produces avoidable death and disease on a massive scale. This injustice can be remedied through a Health Impact Fund that gives patent holders the option to price any new medicine at cost in exchange for annual reward payments based on this medicine's global health impact.
Advance Market Commitment; Disease; Health Impact Fund; Incentives; Justice; Medicine; Monopoly; Patent; Poverty; Public good; Research; Rights; TRIPS